Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2014-11-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
NCT02851147
Swept Source Enhanced Depth Imaging Optical Coherence Tomography
NCT02443129
Topcon 3D OCT-1000 Optical Coherence Tomography System
NCT00792259
Non-Invasive Imaging of the Human Eye
NCT02432898
Clinical Validation of New OCT System
NCT01809704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Any Willing and Able Person for Ocular Imaging
Any Willing and Able Person for Ocular Imaging
SL-D301
Slit Lamp
DC-4
Digital Camera Attachment
SL-3G
Slit Lamp
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SL-D301
Slit Lamp
DC-4
Digital Camera Attachment
SL-3G
Slit Lamp
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Topcon Medical Systems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danny Leung
Role: PRINCIPAL_INVESTIGATOR
Topcon Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Topcon Medical Systems, Inc.
Oakland, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOPCON-004-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.